DK1463541T3 - Biomaterialer baseret på hyaluronsyrebenzylester til anti-angiogen terapi i behandling af tumorer - Google Patents

Biomaterialer baseret på hyaluronsyrebenzylester til anti-angiogen terapi i behandling af tumorer

Info

Publication number
DK1463541T3
DK1463541T3 DK03700315.9T DK03700315T DK1463541T3 DK 1463541 T3 DK1463541 T3 DK 1463541T3 DK 03700315 T DK03700315 T DK 03700315T DK 1463541 T3 DK1463541 T3 DK 1463541T3
Authority
DK
Denmark
Prior art keywords
hyaluronic acid
tumors
treatment
benzyl ester
acid benzyl
Prior art date
Application number
DK03700315.9T
Other languages
English (en)
Inventor
Norbert E Fusenig
Hans-Juergen Stark
Michael Willhauck
Alessandra Pavesio
Original Assignee
Fidia Farmaceutici
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici, Deutsches Krebsforsch filed Critical Fidia Farmaceutici
Application granted granted Critical
Publication of DK1463541T3 publication Critical patent/DK1463541T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03700315.9T 2002-01-11 2003-01-07 Biomaterialer baseret på hyaluronsyrebenzylester til anti-angiogen terapi i behandling af tumorer DK1463541T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002PD000003A ITPD20020003A1 (it) 2002-01-11 2002-01-11 Biomateriali a base di acido ialuronico come terapia anti-angiogenicanella cura dei tumori.
PCT/EP2003/000078 WO2003057203A2 (en) 2002-01-11 2003-01-07 Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumours

Publications (1)

Publication Number Publication Date
DK1463541T3 true DK1463541T3 (da) 2010-03-08

Family

ID=11452500

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03700315.9T DK1463541T3 (da) 2002-01-11 2003-01-07 Biomaterialer baseret på hyaluronsyrebenzylester til anti-angiogen terapi i behandling af tumorer

Country Status (12)

Country Link
US (1) US7838510B2 (da)
EP (1) EP1463541B1 (da)
JP (1) JP4603263B2 (da)
AT (1) ATE448809T1 (da)
AU (1) AU2003201618B2 (da)
CA (1) CA2472880C (da)
DE (1) DE60330113D1 (da)
DK (1) DK1463541T3 (da)
ES (1) ES2334497T3 (da)
IT (1) ITPD20020003A1 (da)
PT (1) PT1463541E (da)
WO (1) WO2003057203A2 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20040312A1 (it) * 2004-12-15 2005-03-15 Fidia Advanced Biopolymers Srl Protesi e o supporto per la sostituzione, riparazione, rigenerazione del menisco

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6117A (ja) * 1984-06-11 1986-01-06 Seikagaku Kogyo Co Ltd ムコ多糖系癌転移抑制剤
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
IT1254704B (it) * 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
CA2094203A1 (en) * 1993-04-16 1994-10-17 Derek A. Willoughby Inhibition of angiogenesis
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
AU718484B2 (en) * 1995-08-29 2000-04-13 Fidia Advanced Biopolymers S.R.L. Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivatives
DK0971961T3 (da) * 1997-04-04 2003-03-24 Fidia Advanced Biopolymers Srl N-sulfaterede hyaluronsyreforbindelser, derivater deraf og en fremgangsmåde til deres fremstilling
IT1293484B1 (it) * 1997-06-11 1999-03-01 Fidia Advanced Biopolymers Srl Materiale biologico comprendente una efficiente coltura di cellule e una matrice tridimensionale biocompatibile e biodegradabile
US6872819B1 (en) * 1998-05-27 2005-03-29 Fidia Advanced Biopolymers S.R.L. Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
ITPD980169A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
CA2365767A1 (en) * 1999-03-15 2000-09-21 Trustees Of Boston University Angiogenesis inhibition
DK1165112T3 (da) 1999-03-26 2006-10-09 Univ Texas Modulatorer af polysaccharider og anvendelser deraf
IT1317359B1 (it) 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e
IT1317358B1 (it) * 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
WO2002041877A1 (en) * 2000-10-24 2002-05-30 Clear Solutions Biotech, Inc. Sodium hyaluronate microspheres

Also Published As

Publication number Publication date
WO2003057203A2 (en) 2003-07-17
JP2005524619A (ja) 2005-08-18
ATE448809T1 (de) 2009-12-15
ITPD20020003A1 (it) 2003-07-11
PT1463541E (pt) 2010-01-07
ES2334497T3 (es) 2010-03-11
DE60330113D1 (de) 2009-12-31
EP1463541B1 (en) 2009-11-18
JP4603263B2 (ja) 2010-12-22
US7838510B2 (en) 2010-11-23
CA2472880A1 (en) 2003-07-17
AU2003201618A1 (en) 2003-07-24
AU2003201618B2 (en) 2008-11-06
EP1463541A2 (en) 2004-10-06
US20050037049A1 (en) 2005-02-17
WO2003057203A3 (en) 2003-12-31
CA2472880C (en) 2011-08-16

Similar Documents

Publication Publication Date Title
DK1201639T3 (da) Lipoxinforbindelser og deres anvendelse til behandling af celleproliferative lidelser
HK1050860A1 (en) Nordihydroguaiaretic derivatives for use in treatment of tumors
DE60037394D1 (de) VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE
NO20050450L (no) Kombinasjon av ZD6474, en inhibitor av vaskulaer endotelial vekst faktor reseptor, med radioterapi ved behandling av kreft
NO20014560L (no) Quinasoliner og terapautisk anvendelse derav
TW200501960A (en) Synergistic kits and compositions for treating cancer
NO20071426L (no) Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib
ATE448812T1 (de) Beschichtung von stents mit verzögerter wirkstofffreisetzung
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
MY138883A (en) Use of asiatic acid for treatment of cencer
AR012626A1 (es) Una composicion farmaeutica que comprende un derivado o análogo de leptina como inhibidor de la proliferacion de células de tumor y el uso de dicha composicion farmaceutica para la manufactura de medicamento para el tratamiento de tumores
DE602004005814D1 (de) Verfahren zur behandlung von übelkeit, erbrechen, würgereiz oder jede kombination daraus
DE50014532D1 (de) Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
NO20053903L (no) Nukleotidlipidesterderivater.
IS5570A (is) Meðhöndlun á risaeitlingasarkmeini með tálmum viðeitilfrumueiturslóðinni
DK0971710T3 (da) Anvendelse af chelerythrin og stråling til tumorterapi
AU3919001A (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
DK1463541T3 (da) Biomaterialer baseret på hyaluronsyrebenzylester til anti-angiogen terapi i behandling af tumorer
HK1074840A1 (en) Novel dithiolopyrrolones with therapeutic activity
HK1079116A1 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
WO2004022001A3 (en) Compositions and methods for inhibiting proliferation in human prostate cancer cells
UA22085A (uk) Спосіб рекоhструкції біфуркації трахеї після її широкої резекції
CY1114651T1 (el) Φαρμακευτικο σκευασμα που περιλαμβανει β-καρβολινη και η χρηση του για τη θεραπεια της σεξουαλικης δυσλειτουργιας
UA33328A (uk) Спосіб лікування механічної жовтяниці
UA36252A (uk) Спосіб визначення індивідуальності хворого для вибору адекватної гомеопатичної терапії